In prostate cancer (PCa) and NSCLC, MAOA was shown to promote the epithelial-to-mesenchymal transition (EMT) and metastasis by stabilizing hypoxia-inducible factor 1α (HIF1α) [11,12]. This evidence concerns the gene MAOA and non-small cell lung carcinoma.